CRISP-11 inhibitors are a specialized class of compounds targeting the cysteine-rich secretory protein (CRISP) family, specifically the CRISP-11 variant. CRISP-11, like its relatives, is characterized by its cysteine-rich domains, which facilitate various protein-protein interactions and contribute to its regulatory functions in cellular processes. These proteins play crucial roles in modulating ion channels, influencing cell adhesion, and participating in immune responses. The inhibition of CRISP-11 is of particular interest because it can impact several physiological processes, such as cellular signaling pathways and immune cell interactions, making it a target for understanding complex biological mechanisms.
The development of CRISP-11 inhibitors involves a detailed approach that includes high-throughput screening techniques to identify potential inhibitory compounds, alongside structure-activity relationship (SAR) studies. These studies focus on understanding how modifications to the chemical structure of candidates can enhance binding affinity and specificity for CRISP-11. Biochemical assays are employed to assess the potency of these inhibitors, measuring their effects on CRISP-11 activity and subsequent downstream signaling events. As researchers delve deeper into the functional roles of CRISP-11 within various biological systems, CRISP-11 inhibitors serve as critical tools for investigating the intricate pathways in which these proteins are involved. This research not only sheds light on CRISP-11's role but also enhances the overall understanding of the CRISP protein family and their broader implications in cellular biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR pathway, which could be upstream of CRISP-11, potentially reducing protein synthesis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, potentially impacting the Akt pathway which may regulate CRISP-11 activity or expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which may affect the MAPK/ERK pathway, potentially altering CRISP-11 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAP kinase, potentially affecting CRISP-11-related stress response pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which could influence apoptosis or other cellular processes that involve CRISP-11. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2, potentially affecting the MAPK/ERK pathway and thereby CRISP-11 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, which could affect various signaling pathways including those involving CRISP-11. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $102.00 $138.00 | 14 | |
Inhibits AKT, potentially downregulating pathways that could activate CRISP-11. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Inhibits Src family kinases, potentially affecting signaling pathways that involve CRISP-11. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $88.00 $311.00 | 17 | |
Inhibits protein kinase C, which may be involved in signaling pathways that regulate CRISP-11 activity. |